{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:38:41Z","timestamp":1773772721360,"version":"3.50.1"},"reference-count":32,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dokl Biochem Biophys"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1134\/s1607672925700073","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T10:28:50Z","timestamp":1747045730000},"page":"315-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunophenotypes of Systemic Lupus Erythematosus\u2014Features of Clinical and Laboratory Disorders"],"prefix":"10.1134","volume":"522","author":[{"given":"A. S.","family":"Avdeeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. P.","family":"Aleksankin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. V.","family":"Chetina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu. N.","family":"Gorbunova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. V.","family":"Popkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A.","family":"Markova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. A.","family":"Panafidina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. L.","family":"Nasonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2025,5,11]]},"reference":[{"key":"7690_CR1","first-page":"397","volume":"60","author":"E.L. Nasonov","year":"2022","unstructured":"Nasonov, E.L., Soloviev, S.K., and Arshinov, A.V., Systemic lupus erythematosus: history and modernity, Nauchno-Prakt. Revmatol., 2022, vol. 60, no. 4, pp.\u00a0397\u2013412.","journal-title":"Nauchno-Prakt. Revmatol"},{"key":"7690_CR2","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"G.C. Tsokos","year":"2011","unstructured":"Tsokos, G.C., Systemic lupus erythematosus, N. Engl. J. Med., 2011, vol. 365, pp. 2110\u20132121.","journal-title":"N. Engl. J. Med."},{"key":"7690_CR3","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/art.40180","volume":"69","author":"N.S. Kubo","year":"2017","unstructured":"Kubo, N.S., Yoshikawa, M., Miyazaki, Y., Sakata, K., and Nakano, K., Peripheral immunophenotyping identi fies three subgroups based on T cell eterogeneity in lupus patients, Arthritis Rheum., 2017, vol. 69, no. 10, pp. 2029\u20132037.","journal-title":"Arthritis Rheum."},{"key":"7690_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ni.3175","volume":"16","author":"C.M. Tipton","year":"2015","unstructured":"Tipton, C.M., Fucile, C.F., Darce, J., Chida, A., and Ichikawa, T., Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus, Nat. Immunol., 2015, vol. 16, no. 7, pp. 755\u2013765.","journal-title":"Nat. Immunol."},{"key":"7690_CR5","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1177\/0961203316643172","volume":"25","author":"S. Iwata","year":"2016","unstructured":"Iwata, S. and Tanaka, Y., B-cell subsets, signaling and their roles in secretion of autoantibodies, Lupus, 2016, vol. 25, no. 8, pp. 850\u2013856.","journal-title":"Lupus"},{"key":"7690_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clim.2017.07.010","volume":"186","author":"Y. Tanaka","year":"2018","unstructured":"Tanaka, Y., Kubo, S., Iwata, S., Yoshikawa, M., and Nakayamada, S., B cell phenotypes, signaling and their roles in secretion of antibodies in systemic lupus erythematosus, Clin. Immunol., 2018, vol. 186, pp. 21\u201325.","journal-title":"Clin. Immunol."},{"key":"7690_CR7","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1084\/jem.20090247","volume":"206","author":"M.P. Longhi","year":"2009","unstructured":"Longhi, M.P., Trumpfheller, C., Idoyaga, J., Caskey, M., and Matos, I., Dendritic cells require a systemic type I interferon response to mature and induce CD4 + Th1 immunity with poly IC as adjuvant, J. Exp. Med., 2009, vol. 206, pp. 1589\u20131602.","journal-title":"J. Exp. Med."},{"key":"7690_CR8","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.4049\/jimmunol.176.4.2074","volume":"176","author":"A. Le Bon","year":"2006","unstructured":"Le Bon, A., Thompson, C., Kamphuis, E., Durand, V., Rossmann, C., et al., Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN, J. Immunol., 2006, vol. 176, pp.\u00a02074\u20132078.","journal-title":"J. Immunol."},{"key":"7690_CR9","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"E.C. Baechler","year":"2003","unstructured":"Baechler, E.C., Batliwalla, F.M., Karypis, G., Gaffney, P.M., and Ortmann, W.A., Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus, Proc. Natl. Acad. Sci. U. S. A., 2003, vol. 100, pp. 2610\u20132615.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"7690_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.14412\/1995-4484-2019-452-461","volume":"57","author":"E.L. Nasonov","year":"2019","unstructured":"Nasonov, E.L. and Avdeeva, A.S., Immunoinflammatory rheumatic diseases associated with type I interferon: new evidence, Rheumatol. Sci. Pract., 2019, vol. 57, no. 4, pp. 452\u2013461.","journal-title":"Rheumatol. Sci. Pract."},{"key":"7690_CR11","first-page":"418","volume":"62","author":"E.V. Suponitskaya","year":"2017","unstructured":"Suponitskaya, E.V., Aleksankin, A.P., Mesnyankina,\u00a0\u00a0A.A., Alexandrova, E.N., Panafidina, T.A., and Soloviev, S.K., The characteristic of sub-populations of B-lymphocytes of peripheral blood in patients with systemic lupus erythematosus, Klin. Lab. Diagn., 2017, vol.\u00a062, no. 7, pp. 418\u2013422.","journal-title":"Klin. Lab. Diagn."},{"key":"7690_CR12","first-page":"27","volume":"19","author":"E.V. Suponitskaya","year":"2016","unstructured":"Suponitskaya, E.V., Aleksankin, A.P., Mesnyankina, A.A., Panafidina, T.A., and Soloviev, S.K., Association of increased friquencies of peripheral blood double-negative (IgD-CD27-) V-cell subset with disease activity in systemic lupus erythematosus, Med. Alphabet, 2016, vol.\u00a019, pp. 27\u201328.","journal-title":"Med. Alphabet"},{"key":"7690_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.14412\/1995-4484-2017-252-260","volume":"55","author":"A.A. Mesnyankina","year":"2017","unstructured":"Mesnyankina, A.A., Solovyev, S.K., Aleksandrova, E.N., Aleksankin, A.P., Suponitskaya, E.V., Elonakov, A.V., Aseeva, E.A., and Nasonov, E.L., The time course of changes in B lymphocyte subpopulations in patients with systemic lupus erythematosus during therapy with biological agents, Rheumatol. Sci. Pract., 2017, vol. 55, no. 3, pp. 252\u2013260.","journal-title":"Rheumatol. Sci. Pract."},{"key":"7690_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/ar3042","volume":"12","author":"B. Rodr\u00edguez-Bayona","year":"2010","unstructured":"Rodr\u00edguez-Bayona, B., Ramos-Amaya, A., Venegas, P., Rodr\u00edguez, J.J., Brieva, C., and A, J., Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients, Arthritis Res. Ther., 2010, vol. 12, no. 3, p. 108.","journal-title":"Arthritis Res. Ther."},{"key":"7690_CR15","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1136\/annrheumdis-2018-213615","volume":"77","author":"K. Ma","year":"2018","unstructured":"Ma, K., Li, J., Wang, X., Lin, X., Du, W., Yang, X., Mou, F., Fang, Yo., Zhao, Ya., Hong, X., Chan, K.W., Zhang, \u00a0X., \u00a0Liu, \u00a0D., \u00a0Sun, \u00a0L., \u00a0and \u00a0Lu, \u00a0L.,\u00a0 TLR4 + CXCR4 + plasma cells drive nephritis development in systemic lupus erythematosus, Ann. Rheum. Dis., 2018, vol. 77, no. 10, pp. 1498\u20131506. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213615","journal-title":"Ann. Rheum. Dis."},{"key":"7690_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/ard.2008.096495","volume":"69","author":"A.M. Jacobi","year":"2010","unstructured":"Jacobi, A.M., Mei, H., Hoyer, B.F., Mumtaz, I.M., and Thiele, K., HLA-DRhigh\/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus, Ann. Rheum. Dis., 2010, vol. 69, no. 1, pp. 305\u2013308.","journal-title":"Ann. Rheum. Dis."},{"key":"7690_CR17","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/art.40653","volume":"70","author":"D. Toro-Dom\u00ednguez","year":"2018","unstructured":"Toro-Dom\u00ednguez, D., Martorell-Marug\u00e1n, J., Goldman, D., Petri, M., and Carmona-S\u00e1ez, P., Longitudinal stratification of gene expression reveals three SLE groups of disease activity progression, Arthritis Rheum., 2018, vol. 70, no. 12, pp. 2025\u20132035.","journal-title":"Arthritis Rheum."},{"key":"7690_CR18","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M. Petri","year":"2012","unstructured":"Petri, M., Orbai, A.M., Alarc\u00f3n, G.S., Gordon, C., and Merrill, J.T., Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum., 2012, vol. 64, no. 8, pp. 2677\u20132686.","journal-title":"Arthritis Rheum."},{"key":"7690_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S. Miyakis","year":"2006","unstructured":"Miyakis, S., Lockshin, M.D., and Atsumi, T., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J. Thromb. Haemost., 2006, vol. 4, no. 2, pp.\u00a0295\u2013306.","journal-title":"J. Thromb. Haemost."},{"key":"7690_CR20","unstructured":"Nasonov, E.L., Rossiiskie klinicheskie rekomendatsii. Revmatologiya (Russian Clinical Guidelines. Rheumatology), Moscow: GEOTAR-Media, 2017."},{"key":"7690_CR21","first-page":"288","volume":"29","author":"D.D. Gladman","year":"2002","unstructured":"Gladman, D.D., Ibanez, D., and Urowitz, M.B., Systemic lupus erythematosus disease activity index 2000, J. Rheumatol., 2002, vol. 29, pp. 288\u2013291.","journal-title":"J. Rheumatol."},{"key":"7690_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.1780390303","volume":"39","author":"D.D. Gladman","year":"1996","unstructured":"Gladman, D.D., Ginzler, E., Goldsmith, C., Fortin, P., Lianget, M., and Al, The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology (SLICC\/ACR) Damage Index for Systemic Lupus Erythematosus, Arthritis Rheum., 1996, vol. 39, no. 3, pp. 363\u2013369.","journal-title":"Arthritis Rheum."},{"key":"7690_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","volume":"165","author":"R. Banchereau","year":"2016","unstructured":"Banchereau, R., Hong, S., Cantarel, B., Baldwin, N., and Baisch, J., Personalized immunomonitoring uncovers molecular networks that stratify lupus patients, Cell, 2016, vol. 165, pp. 551\u2013565.","journal-title":"Cell"},{"key":"7690_CR24","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/s41591-022-01880-6","volume":"28","author":"J.M. Guthridge","year":"2022","unstructured":"Guthridge, J.M., Wagner, C.A., and James, J.A., The promise of precision medicine in rheumatology, Nat. Med., 2022, vol. 28, no. 7, pp. 1363\u20131371.","journal-title":"Nat. Med."},{"key":"7690_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.berh.2017.10.003","volume":"31","author":"A.A. Bengtsson","year":"2017","unstructured":"Bengtsson, A.A. and R\u00f6nnblom, L., Role of interferons in SLE, Best Pract. Res. Clin. Rheumatol., 2017, vol. 31, no. 3, pp. 415\u2013428.","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"7690_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00109-016-1421-4","volume":"94","author":"M.L. Eloranta","year":"2016","unstructured":"Eloranta, M.L. and L, R.N., Cause and consequences of the activated type I interferon system in SLE, J. Mol. Med. (Berl.), 2016, vol. 94, no. 10, pp. 1103\u20131110.","journal-title":"J. Mol. Med. (Berl.)"},{"key":"7690_CR27","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/art.30187","volume":"63","author":"C.E. Weckerle","year":"2011","unstructured":"Weckerle, C.E., Franek, B.S., and Kelly, J.A., Network analysis of associations between erum interferon-\u03b1 activity, autoantibodies, and clinical features in systemic lupus rythematosus, Arthritis Rheum., 2011, vol. 63, no.\u00a04, pp. 1044\u20131053.","journal-title":"Arthritis Rheum."},{"key":"7690_CR28","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/biom13060960","volume":"13","author":"S. Nakayamada","year":"2023","unstructured":"Nakayamada, S. and Tanaka, Y., Immune phenotype as a biomarker for systemic lupus erythematosus, Biomolecules, 2023, vol. 13, no. 6, p. 960.","journal-title":"Biomolecules"},{"key":"7690_CR29","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/art.40180","volume":"69","author":"S. Kubo","year":"2017","unstructured":"Kubo, S., Nakayamada, S., Yoshikawa, M., Miyazaki, Y., and Sakata, K., Peripheral immunophenotyping identifies three subgroups based on T cell heterogeneity in lupus patients, Arthritis Rheum., 2017, vol. 69, pp.\u00a02029\u20132037.","journal-title":"Arthritis Rheum."},{"key":"7690_CR30","first-page":"32","volume":"54","author":"J. Kosalka","year":"2016","unstructured":"Kosalka, J., Jakiela, B., and Musial, J., Changes of memory B- and T-cell subsets in lupus nephritis patients, Folia Histochem. Cytobiol., 2016, vol. 54, no. 1, pp. 32\u201341.","journal-title":"Folia Histochem. Cytobiol."},{"key":"7690_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/1756-185X.12534","volume":"18","author":"S. Nakayamada","year":"2015","unstructured":"Nakayamada, S., Iwata, S., and Tanaka, Y., Relevance of lymphocyte subsets to B cell targeted therapy in systemic lupus erythematosus, Int. J. Rheum. Dis., 2015, vol. 18, no. 2, pp. 208\u2013218.","journal-title":"Int. J. Rheum. Dis."},{"key":"7690_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10067-017-3877-1","volume":"37","author":"L. Zhu","year":"2018","unstructured":"Zhu, L., Yin, Z., Ju, B., Zhang, J., and Wang, Y., Altered frequencies of memory B cells in new-onset systemic lupus erythematosus patients, Clin. Rheumatol., 2018, vol. 37, pp. 205\u2013212.","journal-title":"Clin. Rheumatol."}],"container-title":["Doklady Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672925700073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S1607672925700073","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672925700073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:21:46Z","timestamp":1773760906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S1607672925700073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7690"],"URL":"https:\/\/doi.org\/10.1134\/s1607672925700073","relation":{},"ISSN":["1607-6729","1608-3091"],"issn-type":[{"value":"1607-6729","type":"print"},{"value":"1608-3091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,11]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee (protocol no. 25 dated December 23, 2021). All patients signed informed consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS APPROVAL AND CONSENT TO PARTICIPATE"}},{"value":"The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}}]}}